Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose zoledronate versus standard dose and placebo in postmenopausal women with osteopenia
ACTRN12607000576426Phase 4Completed
- Sponsor
- The University of Auckland
- Start
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of zoledronate in osteopenia and osteoporosis (4 arms), sponsored by The University of Auckland. Primary endpoint: Change in lumbar spine bone density. Started Jan 2008; status: completed.
02
Drugs
zoledronate
03
Conditions
osteopeniaosteoporosis
Beyond the preview
Go deeper on ACTRN12607000576426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12607000576426.